Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-06

FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approved the generic combination product Losartan Potassium and Hydrochlorothiazide from Solco Healthcare US, LLC under an original application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan potassium and hydrochlorothiazide (losartan potassium and hydrochlorothiazide)

Snippet

ORIG AP for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)